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Background: Longevity-associated mitochondrial DNA 5178 (Mt5178) C/A reportedly modulates the effects of
coffee consumption on the risk of hypertension, dyslipidemia and abnormal glucose tolerance, and those of alcohol
consumption on the risk of hypertension, dyslipidemia and hyperuricemia in middle-aged Japanese men. However,
there has been no research examining whether Mt5178 C/A polymorphism influences the effects of coffee
consumption or alcohol consumption on the clustering of cardiovascular risk factors (CRFs).
Methods: A total of 332 male subjects (mean age ± SD, 52.8 ± 7.8 years) were selected from among individuals
visiting the hospital for regular medical check-ups. After Mt5178 C/A genotyping, a cross-sectional study assessing
the joint effects of Mt5178 C/A polymorphism and coffee consumption or alcohol consumption on the clustering
of CRFs, namely hypertension, abnormal glucose tolerance, hyper-low-density lipoprotein cholesterolemia, hypo-high
density lipoprotein cholesterolemia, hypertriglyceridemia and hyperuricemia, was then conducted.
Results: After adjustment for confounding factors, significant and negative associations were observed between coffee
consumption and clustering of ≥2 CRFs in subjects with Mt5178C. The adjusted odds ratio (OR) for the clustering of ≥2
or ≥3 CRFs was significantly lower in subjects who consumed 1–3 cups of coffee per day than in those who
consumed <1 cup of coffee per day (OR = 0.496, 95% confidence interval (CI): 0.249–0.989, and OR = 0.369, 95% CI:
0.165–0.826, respectively). On the other hand, after adjustment, positive associations between coffee consumption and
clustering of ≥2 CRFs were observed in subjects with Mt5178A. However, these associations did not reach a significant
level. For Mt5178C genotypic men, the adjusted OR for the clustering of ≥2 or ≥3 CRFs was significantly higher in daily
drinkers than in occasional drinkers (OR = 2.737, 95% CI: 1.361–5.502, and OR = 3.024, 95% CI: 1.269–7.210, respectively).
On the other hand, the association between Mt5178A genotype and the clustering of ≥2 or ≥3 CRFs did not appear to
depend on alcohol consumption.
Conclusions: The present results suggest that Mt5178 C/A polymorphism modifies the effects of coffee consumption
or alcohol consumption on the clustering of CRFs in middle-aged Japanese men.
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Cardiovascular disease (CVD) is public health issue of great
importance. From the standpoint of CVD prevention, it is
absolutely essential to reduce the number of cardiovascular
risk factors (CRFs), namely, hypertension, dyslipidemia, ab-
normal glucose tolerance (AGT) and hyperuricemia [1,2].
Several CRFs evidently provoke mitochondrial damage and
dysfunction [3,4]. Mitochondrial dysfunction results in im-
pairment of oxidative phosphorylation, and increases in
both reactive oxygen species (ROS) and calcium dysregula-
tion. These mitochondria-related adverse effects promote
apoptosis, cellular senescence, and eventually, atheroscler-
osis [4].
Mitochondrial DNA 5178 (Mt5178) C/A polymorphism,
also known as NADH dehydrogenase subunit-2 237 (ND2-
237) Leu/Met, is a longevity-associated mitochondrial DNA
polymorphism [5,6]. The frequency of the Mt5178A geno-
type is significantly higher in Japanese centenarians than in
the general population. Japanese individuals with Mt5178A
are more resistant to atherosclerotic diseases, such as myo-
cardial infarction [7,8] and cerebrovascular disorders [9],
than those with Mt5178C. Our previous studies have re-
ported the joint effects of Mt5178 C/A polymorphism and
coffee consumption on the risk of hypertension [10],
dyslipidemia [11], and AGT [12] in middle-aged Japa-
nese men. We have also reported the combined effects
of Mt5178 C/A polymorphism and alcohol consumption
on the risk of hypertension [13], dyslipidemia [14], and
hyperuricemia [15]. However, an examination of whether
Mt5178 C/A polymorphism influences the effects of cof-
fee and alcohol consumption on clustering of CRFs has
yet to be performed.
The objective of this study was to investigate whether
there is a joint effect of Mt5178 C/A polymorphism and
coffee consumption or alcohol consumption on the clus-
tering of CRFs in middle-aged Japanese male subjects.
Materials and methods
Study subjects
Participants were recruited from among individuals visiting
the Mito Red Cross Hospital for regular medical check-ups
between August 1999 and August 2000. This study was
conducted in accordance with the Declaration of Helsinki
and approved by the Ethics Committee of the Kyorin Uni-
versity School of Medicine. Written informed consent was
obtained from all 602 volunteers before participation. Be-
cause the number of women was insufficient for classifi-
cation into groups based on Mt5178 C/A genotype and
coffee consumption or alcohol consumption habits, they
were excluded. Individuals not receiving 75-g oral glucose
tolerance test were also excluded. Hyper-low-density lipo-
protein (LDL) cholesterolemia, hypo-high-density lipopro-
tein (HDL) cholesterolemia, and hypertriglyceridemia were
regarded as three different CRFs. Therefore, due to a lackof information on the types of lipid-lowering drugs being
used, those taking any lipid-lowering medications were ex-
cluded. Those with unclear data were also excluded. Thus,
the subjects in this study comprised a total of 332 Japanese
men (mean age ± SD, 52.8 ± 7.8 years).
Clinical characteristics of subjects
Determination of blood chemical and physical data was
conducted as described previously [16]. Serum total choles-
terol levels, serum HDL cholesterol levels, serum triglycer-
ide levels, fasting plasma glucose (FPG) levels and serum
uric acid levels were measured using standard laboratory
techniques. Serum LDL cholesterol levels were calculated
by Friedewald’s formula [17]. For both systolic blood pres-
sure (SBP) and diastolic blood pressure (DBP), the mean
of two consecutive values measured by physicians was
used. Body mass index (BMI) was defined as the ratio of
subject weight (kg) to the square of subject height (m).
Hypertension was defined as SBP ≥140 mmHg and/or
DBP ≥90 mmHg and/or antihypertensive drug treatment.
AGT was defined as FPG ≥110 mg/dl and/or 2-h plasma
glucose on the 75-g oral glucose tolerance test ≥140 mg/dl,
or diagnosed with diabetes. According to the Japan Athero-
sclerosis Society guidelines for prevention of atherosclerotic
cardiovascular diseases [18], hyper-LDL cholesterolemia
was defined as serum LDL cholesterol ≥140 mg/dl, hypo-
HDL cholesterolemia was defined as serum HDL choles-
terol <40 mg/dl, and hypertriglyceridemia was defined as
serum triglyceride ≥150 mg/dl. Similar to other studies
on clustering of CRFs [19,20], hyperuricemia was defined
as serum uric acid ≥7.0 mg/dl. The number of CRFs was
calculated by adding the number of these components,
namely hypertension, AGT, hyper-LDL cholesterolemia,
hypo-HDL cholesterolemia, hypertriglyceridemia and hy-
peruricemia. Therefore, the number of CRFs varied from
0 to 6 in integral values. A questionnaire survey of coffee
intake, alcohol consumption, and habitual smoking was
also conducted. Coffee consumption was classified based
on number of cups of coffee per day (<1 cup per day; 1–3
cups per day; and ≥4 cups per day). Alcohol consumption
was classified based on drinking frequency (daily drinkers;
occasional drinkers, which include those who drink several
times per week or per month; and non- or ex-drinkers).
Smoking status was classified based on number of ciga-
rettes smoked per day (never- or ex-smokers; 1–20 ciga-
rettes smoked per day; and >20 cigarettes smoked per day).
Genotyping
DNA was extracted from white blood cells using the
DNA Extractor WB kit (Wako Pure Chemical Industries,
Japan). Mt5178 C/A polymorphism was detected by poly-
merase chain reaction (PCR) and digestion with AluI re-
striction enzyme. The sequence of primers was: forward
5′-CTTAGCATACTCCTCAATTACCC-3′, reverse 5′-GT
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with 50 ng of genomic DNA in buffer containing 0.2 μmol/l
each primer, 1.25 mmol/l dNTPs, 1.5 mmol/l MgCl2, and 1
U of Taq DNA polymerase. After an initial denaturation at
94°C for 5 min, PCR was conducted through 40 cycles in
the following steps: denaturation at 94°C for 30 s, annealing
at 60°C for 60 s, and polymerase extension at 72°C for 90 s.
After cycling, a final extension at 72°C for 10 min was per-
formed. PCR products were digested with AluI restriction
enzyme (Nippon Gene, Japan) at 37°C overnight and elec-
trophoresed on 1.5% agarose gels stained with ethidium
bromide for visualization under ultraviolet light. The ab-
sence of an AluI site was designated as Mt5178A (279-bp
fragment), and the presence of this restriction site was des-
ignated as Mt5178C (175-bp and 104-bp fragments).
Statistical analyses
Statistical analyses were performed using SAS statistical
software for Windows (version 9.3, SAS Institute Inc.,
Cary, NC). Multiple logistic regression analysis was used
to calculate the odds ratio (OR) for the clustering of
CRFs, namely more than 2 or 3 CRF components. For
multiple logistic regression analysis, coffee consumption
(<1 cup per day = 1, 1–3 cups per day = 2, ≥4 cups per
day = 3), alcohol consumption (non- or ex-drinkers = 0,
occasional drinkers, which include those who drink sev-
eral times per week or per month = 1, daily drinkers = 2),
and habitual smoking (never- or ex-smokers = 0, 1–20
cigarettes smoked per day = 1, >20 cigarettes smoked per
day = 2) were numerically coded. Based on previous re-
ports [10-15], subjects consuming <1 cup of coffee per
day and occasional drinkers were used for reference. Dif-
ferences with P values less than 0.05 were considered to
be statistically significant.
Results
No significant differences were observed between the
Mt5178C and Mt5178A genotypes in biophysical or bio-
chemical characteristics or in frequencies of CRFs, namely
hypertension, AGT, hyper-LDL cholesterolemia, hypo-HDL
cholesterolemia, hypertriglyceridemia and hyperuricemia
(Table 1).
Among subjects with Mt5178C, frequencies of those
with 0, 1, 2, 3, 4 and 5 CRFs were 25.4%, 26.9%, 25.4%,
15.2%, 5.6% and 1.5%, respectively (Figure 1). Among
subjects with Mt5178A, frequencies of those with 0, 1, 2,
3, 4 and 5 CRFs were 26.7%, 32.6%, 22.9%, 11.1%, 5.2%
and 1.5%, respectively. No subjects had 6 CRFs in either
the Mt5178C or the Mt5178A genotype. A chi-square
test did not show a statistically significant difference be-
tween the Mt5178C and Mt5178A genotypes in the fre-
quencies of subjects with number of CRFs (P = 0.827).
After adjustment for age and BMI or for age, BMI, ha-
bitual smoking and alcohol consumption, significant andnegative associations were observed between coffee con-
sumption and the clustering of ≥2 CRFs in subjects with
Mt5178C (P for trend = 0.030 and P for trend = 0.014,
respectively) (Table 2). Although the crude OR for the
clustering of ≥2 CRFs was not significant, after adjust-
ment for age, BMI, habitual smoking and alcohol con-
sumption, the OR for the clustering of ≥2 CRFs was
significantly lower both in subjects who consumed 1–3
cups of coffee per day and in those who consumed ≥4 cups
of coffee per day, as compared to those who consumed <1
cup of coffee per day (OR = 0.496, 95% confidence interval
(CI): 0.249-0.989, P = 0.047 and OR = 0.259, 95% CI: 0.074-
0.901, P = 0.034, respectively). These results indicate that
the covariates, namely age, BMI, habitual smoking and al-
cohol consumption, were potential confounding factors.
Moreover, the crude OR for clustering of ≥3 CRFs was sig-
nificantly lower in subjects who consumed 1–3 cups of
coffee per day than in those who consumed <1 cup of cof-
fee per day (OR = 0.451, 95% CI: 0.216–0.940, P = 0.034).
After adjustment for age and BMI or for age, BMI, habitual
smoking and alcohol consumption, a significant OR re-
mained (OR = 0.376, 95% CI: 0.171–0.824, P = 0.015 and
OR = 0.369, 95% CI: 0.165–0.826, P = 0.015, respectively).
However, negative associations between coffee consump-
tion and the clustering of ≥3 CRFs did not reach a signifi-
cant level for either adjustment (P for trend = 0.097 or P
for trend = 0.069, respectively). On the other hand, after
both adjustments, positive associations between coffee
consumption and the clustering of ≥2 CRFs were observed
in subjects with Mt5178A; however, these associations did
not reach a level of significance (P for trend = 0.059 or P
for trend = 0.068, respectively).
For Mt5178C genotypic men, the crude OR for the clus-
tering of ≥2 CRFs was significantly higher in daily drinkers
than in occasional drinkers (OR = 2.391, 95% CI: 1.258–
4.542, P = 0.008) (Table 3). After adjustment for age and
BMI or for age, BMI, habitual smoking and coffee con-
sumption, a significant OR remained (OR = 2.539, 95% CI:
1.293–4.984, P = 0.007 and OR = 2.737, 95% CI: 1.361–
5.502, P = 0.005, respectively). Moreover, the crude OR for
the clustering of ≥3 CRFs was significantly higher in daily
drinkers than in occasional drinkers (OR = 2.984, 95% CI:
1.293–6.882, P = 0.010). After both adjustments, a signifi-
cant OR also remained (OR = 2.918, 95% CI: 1.241–6.861,
P = 0.014 and OR = 3.024, 95% CI: 1.269–7.210, P = 0.013,
respectively). On the other hand, the association between
Mt5178A genotype and the clustering of ≥2 or ≥3 CRFs
does not appear to depend on alcohol consumption.
Discussion
The present study shows a novel gene-environment in-
teraction on the clustering of CRF components such as
hypertension, hypertriglycemia, hypo-HDL cholesterole-
mia, hyper-LDL cholesterolemia, AGT and hyperuricemia.
Table 1 Clinical characteristics of study subjects by Mt5178 C/A genotype
Mt5178C Mt5178A P value
N = 197 N = 135
Age (y) 53.0 ± 7.9 52.6 ± 7.8 0.602
Body mass index (kg/m2) 23.2 ± 2.6 23.6 ± 2.5 0.165
Systolic blood pressure (mmHg) 125.0 ± 15.4 125.2 ± 13.8 0.872
Diastolic blood pressure (mmHg) 72.8 ± 10.1 72.5 ± 8.5 0.788
Total cholesterol (mg/dl) 204.9 ± 35.8 204.8 ± 32.0 0.982
LDL cholesterol (mg/dl) 121.6 ± 36.7 120.6 ± 31.3 0.796
HDL cholesterol (mg/dl) 54.6 ± 13.6 56.2 ± 16.1 0.344
Triglyceride (mg/dl) 143.1 ± 97.5 139.9 ± 90.2 0.764
Fasting plasma glucose (mg/dl) 96.4 ± 8.8 97.1 ± 9.2 0.517
2-h plasma glucose on 75-g oral glucose tolerance test (mg/dl) 128.3 ± 43.3 124.6 ± 37.9 0.433
Uric acid (mg/dl) 5.99 ± 1.24 5.96 ± 1.22 0.798
Coffee consumption (<1 cup per day/1-3 cups per day/≥ 4 cups per day) (%) 40.1/48.7/11.2 39.3/48.9/11.8 0.977
Alcohol consumption (non- or ex-/occasional/daily) (%) 19.3/36.5/44.2 12.6/38.5/48.9 0.267
Smoking status (never- or ex-/1–20 cigarettes per day/>20 cigarettes per day) (%) 57.4/29.4/13.2 58.5/27.4/14.1 0.914
Hypertension (%) 28.4 21.5 0.154
Abnormal glucose tolerance (%) 33.5 31.1 0.648
Hyper-LDL cholesterolemia (%) 27.4 28.9 0.768
Hypo-HDL cholesterolemia (%) 11.2 11.1 0.987
Hypertriglyceridemia (%) 32.0 28.2 0.456
Hyperuricemia (%) 20.8 19.3 0.729
LDL; low-density lipoprotein, HDL; high-density lipoprotein. Age, body mass index, systolic blood pressure, diastolic blood pressure, serum total cholesterol levels,
serum LDL cholesterol levels, serum HDL cholesterol levels, serum triglyceride levels, fasting plasma glucose levels, 2-h plasma glucose levels on 75-g oral glucose
tolerance test and serum uric acid levels are given as means ± S.D. P values were calculated by Student’s t-test. For alcohol consumption, coffee consumption,
smoking status, hypertension, abnormal glucose tolerance, hyper-LDL cholesterolemia, hypo-HDL cholesterolemia, hypertriglyceridemia and hyperuricemia,
P values were calculated by chi-squared test. All P values indicate significance of differences between Mt5178C and Mt5178A.
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Figure 1 Distribution of number of cardiovascular risk factors (CRFs)However, for those with Mt5178A, coffee or alcohol con-
sumption appears to have no influence.
Several clinical epidemiological studies have reported
that Japanese individuals with Mt5178C are more suscep-






between the Mt5178C and Mt5178A genotypes.
Table 2 Odds ratios (ORs) and 95% confidence intervals (CIs) for clustering of CRFs by Mt5178 C/A genotype and
coffee consumption
Genotype and coffee consumption Frequency OR (95% CI) Adjusted OR† (95% CI) Adjusted OR‡ (95% CI)
Number of CRF components
<2 ≥2
Mt5178C
<1 cup per day (%) 37 (46.8) 42 (53.2) 1 (reference) 1 (reference) 1 (reference)
1-3 cups per day (%) 53 (55.2) 43 (44.8) 0.715 (0.393-1.299) 0.536 (0.277-1.037) 0.496 (0.249-0.989)*
≥4 cups per day (%) 13 (59.1) 9 (40.9) 0.610 (0.234-1.590) 0.334 (0.105-1.066) 0.259 (0.074-0.901)*
P for trend = 0.208 P for trend = 0.030 P for trend = 0.014
Mt5178A
<1 cup per day (%) 33 (62.3) 20 (37.7) 1 (reference) 1 (reference) 1 (reference)
1-3 cups per day (%) 39 (59.1) 27 (40.9) 1.142 (0.544-2.397) 1.626 (0.694-3.810) 1.596 (0.638-3.979)
≥4 cups per day (%) 8 (50.0) 8 (50.0) 1.650 (0.535-5.090) 2.989 (0.811-11.01) 3.283 (0.743-14.51)
P for trend = 0.416 P for trend = 0.059 P for trend = 0.068
Number of CRF components
<3 ≥3
Mt5178C
<1 cup per day (%) 56 (70.9) 23 (29.1) 1 (reference) 1 (reference) 1 (reference)
1-3 cups per day (%) 81 (84.4) 15 (15.6) 0.451 (0.216-0.940)* 0.376 (0.171-0.824)* 0.369 (0.165-0.826)*
≥4 cups per day (%) 16 (72.7) 6 (27.3) 0.913 (0.317-2.626) 0.487 (0.136-1.746) 0.402 (0.103-1.568)
P for trend = 0.267 P for trend = 0.097 P for trend = 0.069
Mt5178A
<1 cup per day (%) 43 (81.1) 10 (18.9) 1 (reference) 1 (reference) 1 (reference)
1-3 cups per day (%) 55 (83.3) 11 (16.7) 0.860 (0.334-2.212) 0.938 (0.352-2.495) 0.762 (0.268-2.168)
≥4 cups per day (%) 13 (81.3) 3 (18.7) 0.992 (0.237-4.153) 1.485 (0.313-7.043) 0.735 (0.124-4.359)
P for trend = 0.886 P for trend = 0.840 P for trend = 0.730
CRF; cardiovascular risk factor. †OR adjusted for age and body mass index. ‡OR adjusted for age, body mass index, habitual smoking and habitual alcohol consumption.
*P < 0.05.
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Mt5178C genotypic men, consumption of more than a cup
of coffee per day and abstinence of daily alcohol consump-
tion are recommended. However, this study focused on
one single nucleotide polymorphism, namely Mt5178 C/A
polymorphism. Therefore, to establish the individualized
prevention for cardiovascular diseases, further investiga-
tions scrutinizing gene-gene or gene-environment interac-
tions on CRFs are required [21].
The results of this study do not contradict those of
our previous reports. The present study shows that cof-
fee consumption may decrease the number of CRF com-
ponents among Mt5178C genotypic men, and previous
studies have reported that coffee consumption decreases
the risk of hypertension [10] and AGT [12]. On the other
hand, the present study shows that coffee consumption
may increase the number of CRF components among
Mt5178A genotypic men, and a previous study reported
that coffee consumption increases the risk of hyper-LDL
cholesterolemia among Mt5178A genotypic men [11]. Thepresent study shows a U-shaped association between the
frequency of alcohol consumption and the clustering of
CRFs among Mt5178C genotypic men. Our previous stud-
ies reported that daily alcohol consumption increases the
risk of hypertension [13] or hyperuricemia [15], and de-
creases that of hyper-LDL cholesterolemia [14]. Therefore,
the U-shaped association with the lowest risk of clustering
of CRFs in occasional drinkers is acceptable. In view of the
J-shaped relationship between alcohol consumption and
coronary heart disease [22], the results of this study were
interesting from a preventative medicine perspective.
CRFs overlap with components of metabolic syndrome
(MtS). Although Balk et al. reported that coffee consump-
tion is not associated with any components of MtS in
Dutch men [23], several cross-sectional studies have shown
that coffee consumption is inversely associated with MtS
and the respective components of MtS in the Japanese
population [24-26]. The results of this study showed that
coffee consumption may decrease the clustering of CRFs
in Mt5178C genotypic men, but not in Mt5178A genotypic
Table 3 Odds ratios (ORs) and 95% confidence intervals (CIs) for clustering of CRFs by Mt5178 C/A genotype and
alcohol consumption
Genotype and alcohol consumption Frequency OR (95% CI) Adjusted OR† (95% CI) Adjusted OR‡ (95% CI)
Number of CRF components
<2 ≥2
Mt5178C
Non- or ex-drinkers (%) 20 (52.6) 18 (47.4) 1.592 (0.717-3.537) 2.142 (0.888-5.167) 2.212 (0.855-5.723)
Occasional drinkers (%) 46 (63.9) 26 (36.1) 1 (reference) 1 (reference) 1 (reference)
Daily drinkers (%) 37 (42.5) 50 (57.5) 2.391 (1.258-4.542)** 2.539 (1.293-4.984)** 2.737 (1.361-5.502)**
P for trend = 0.106 P for trend = 0.168 P for trend = 0.172
Mt5178A
Non- or ex-drinkers (%) 9 (52.9) 8 (47.1) 1.679 (0.553-5.098) 1.454 (0.433-4.876) 1.141 (0.352-5.677)
Occasional drinkers (%) 34 (65.4) 18 (34.6) 1 (reference) 1 (reference) 1 (reference)
Daily drinkers (%) 37 (56.1) 29 (43.9) 1.480 (0.699-3.135) 1.656 (0.736-3.725) 1.623 (0.681-3.872)
P for trend = 0.305 P for trend = 0.223 P for trend = 0.275
Number of CRF components
<3 ≥3
Mt5178C
Non- or ex-drinkers (%) 29 (76.3) 9 (23.7) 2.172 (0.781-6.044) 2.525 (0.851-7.492) 2.611 (0.808-8.443)
Occasional drinkers (%) 63 (87.5) 9 (12.5) 1 (reference) 1 (reference) 1 (reference)
Daily drinkers (%) 61 (70.1) 26 (29.9) 2.984 (1.293-6.882)* 2.918 (1.241-6.861)* 3.024 (1.269-7.210)*
P for trend = 0.174 P for trend = 0.218 P for trend = 0.259
Mt5178A
Non- or ex-drinkers (%) 13 (76.5) 4 (23.5) 1.470 (0.388-5.566) 1.301 (0.330-5.132) 1.720 (0.394-7.519)
Occasional drinkers (%) 43 (82.7) 9 (17.3) 1 (reference) 1 (reference) 1 (reference)
Daily drinkers (%) 55 (83.3) 11 (16.7) 0.955 (0.363-2.513) 0.978 (0.364-2.632) 1.023 (0.368-2.844)
P for trend = 0.927 P for trend = 0.965 P for trend = 0.966
CRF; cardiovascular risk factor. †OR adjusted for age and body mass index. ‡OR adjusted for age, body mass index, habitual smoking and coffee consumption.
*P < 0.05, **P < 0.001.
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polymorphism, may modify the relationship between coffee
consumption and components of MtS.
Even employing a systematic overview of 14 observa-
tional studies, the relationship between alcohol con-
sumption and MtS remains controversial [27]. However, a
large-scale prospective cohort study revealed that alcohol
consumption is associated with independent components
of MtS, comprising CRFs [28]. The results of this study
suggested that daily drinking increases the clustering of
CRFs for Mt5178C genotypic men, but not for Mt5178A
genotypic men. Therefore, Mt5178 C/A other genetic
polymorphisms most likely influence the relationship be-
tween alcohol consumption and components of MtS.
The mechanisms underlying the joint effects of Mt5178
C/A (ND2-237 Leu/Met) polymorphism and coffee or
alcohol consumption on the clustering of CRFs remain
unknown. They presumably depend on the amino-acid-
related differences in response to ROS between ND2-
237Leu and ND2-237Met. NADH dehydrogenase, namelycomplex I of the mitochondrial respiratory chain, is a
major source of ROS production, and is a target of ROS
[29]. Both observational and interventional studies have
shown that coffee consumption exerts antioxidant poten-
tial [30,31]. Exertion of antioxidant activity of chlorogenic
acid, caffeine and other natural compounds in coffee may
be higher in men with ND2-237Leu than in those with
ND2-237Met. Ethanol metabolism is directly associated
with ROS production [32]. Alcohol-induced oxidative stress
may be higher in men with ND2-237Leu than in those with
ND2-237Met. The mechanisms responsible for the joint ef-
fects of Mt5178 C/A (ND2-237 Leu/Met) polymorphism
and coffee or alcohol consumption on the clustering of
CRFs remain a matter for further biochemical exploration.
The present study has several crucial limitations. First,
the findings are limited by the small sample size, which was
not sufficient to validate gene-environment interactions.
Moreover, small sample size limited the definition of the
clustering of CRFs as more than 2 or 3 CRF components.
Second, the evaluation of habitual coffee consumption,
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the number of cups consumed per day, and this study
lacked information regarding the method of coffee prep-
aration. Third, the evaluation of habitual alcohol con-
sumption, which we also used in previous studies [13-15],
was based on the frequency of alcohol consumption.
Forth, lack of information on waist circumference affected
the evaluation of MtS as an outcome. By substituting BMI
of ≥25 kg/m2 for waist circumference of ≥85 cm [33], we
attempted to examine the interactions between Mt5178 C/A
polymorphism and coffee consumption or alcohol con-
sumption on the risk of MtS, but did not find any statisti-
cally significant associations in either genotype (data not
shown). Fifth, we lacked information on dietary factors,
which are reportedly related to the number of MtS com-
ponents [34]. To overcome these limitations, a large-scale
well-designed epidemiological study is necessary.
Conclusion
Combined effects of longevity-associated Mt5178 C/A
polymorphism and habitual coffee consumption or habit-
ual alcohol consumption on the clustering of CRFs were
observed in middle-aged Japanese men. For men with
Mt5178C, who are susceptible to CVD, coffee consump-
tion may decrease or daily alcohol consumption may in-
crease the clustering of CRFs. Although further studies will
be required to determine the individualized optimum for
maximizing the risk reduction and minimizing the risk in-
crease of habitual coffee or consumption for the clustering
of CRF components, genetic information on Mt5178 C/A
polymorphism will probably provide personalized pre-
vention for CVD.
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